Business

mass. movers

Zalicus uses reverse split to stay on Nasdaq

Zalicus stock first fell below $1 in September 2012.

Associated Press/File 2012

Zalicus stock first fell below $1 in September 2012.

Advertisement

Zalicus Inc., suffering for a year with a stock price below the minimum required for listing on the Nasdaq, enacted a 6-for-1 reverse split to help it get back in compliance. That cuts the number of shares from 147.5 million to 24.6. Zalicus now expects to meet the $1 minimum for the Nasdaq Capital Market. The reverse split comes less than a week after Zalicus rose more than 30 percent after the FDA granted “orphan” status for its experimental pill to treat shingles pain.

Loading comments...
Real journalists. Real journalism. Subscribe to The Boston Globe today.